Licensed alternatives including semaglutide (Wegovy) and tirzepatide (Mounjaro) are available through NHS or private prescription under current NICE guidance
Depending on the peptide, significant potency can be lost in a matter of hours, not days
RUO materials are not subject to FDA pre-market approval for human administration, cannot be used as drug ingredients in compounding, and are not intended for diagnostic, therapeutic, or veterinary use
Ninety capsules at the same daily dose is fifty percent more product
Each product goes through hundreds of checks, in-process and post-production
Continental Hospitals facilita el acceso a medicamentos modernos como la semaglutida y ofrece asesoramiento mdico completo para su uso seguro